1. The effect of metformin on lung cancer risk and survival in patients with type 2 diabetes mellitus: A meta‐analysis
   Kang Xiao et al, 2020, Journal of Clinical Pharmacy and Therapeutics CrossRef
2. Animal models and in vivo investigations for drug repurposing in lung cancer
   Hsuen-Wen Kate Chang et al, 2020, Drug Repurposing in Cancer Therapy CrossRef
3. Research progress on the therapeutic effect and mechanism of metformin for lung cancer (Review)
   Pengkai Han et al, 2022, Oncology Reports CrossRef
4. Metformin in Lung Cancer: Review of in Vitro and in Vivo Animal Studies
   Michael Yousef et al, 2017, Cancers CrossRef
5. Butein sensitizes HeLa cells to cisplatin through the AKT and ERK/p38 MAPK pathways by targeting FoxO3a
   LIRUI ZHANG et al, 2015, International Journal of Molecular Medicine CrossRef
6. Metformin: A Dual-Role Player in Cancer Treatment and Prevention
   Mariam Ahmed Galal et al, 2024, International Journal of Molecular Sciences CrossRef
7. Molecular mechanisms underlining the role of metformin as a therapeutic agent in lung cancer
   Ali Fatehi Hassanabad et al, 2021, Cellular Oncology CrossRef
8. Metformin induces ferroptosis through the Nrf2/HO-1 signaling in lung cancer
   Chengmin Deng et al, 2023, BMC Pulmonary Medicine CrossRef
9. Metformin synergistic pemetrexed suppresses non‐small‐cell lung cancer cell proliferation and invasion in vitro
   Yan Zhang et al, 2017, Cancer Medicine CrossRef
10. Lipopolysaccharide-Binding Protein Downregulates Fractalkine through Activation of p38 MAPK and NF-κB
    Xia Huang et al, 2017, Mediators of Inflammation CrossRef
11. The role of metformin in the treatment of non-small cell lung cancer
    Jelena Ljubičić et al, 2022, Zdravstvena zastita CrossRef
12. Regulation of MAPKs Signaling Contributes to the Growth Inhibition of 1,7-Dihydroxy-3,4-dimethoxyxanthone on Multidrug Resistance A549/Taxol Cells
    Jian Zuo et al, 2016, Evidence-Based Complementary and Alternative Medicine CrossRef
13. New derivative of 2-(2,4-dihydroxyphenyl)thieno-1,3-thiazin-4-one (BChTT) elicits antiproliferative effect via p38-mediated cell cycle arrest in cancer cells
    Małgorzata Juszczak et al, 2016, Bioorganic & Medicinal Chemistry CrossRef
14. Metformin therapy associated with survival benefit in lung cancer patients with diabetes
    Guoxing Wan et al, 2016, Oncotarget CrossRef
15. Progress in the application and mechanism of metformin in treating non-small cell lung cancer
    Chan Li et al, 2017, Oncology Letters CrossRef
16. Targeting TAM-secreted S100A9 effectively enhances the tumor-suppressive effect of metformin in treating lung adenocarcinoma
    Qihai Sui et al, 2024, Cancer Letters CrossRef
17. TNF-α controls Lipocalin-2 expression in PC-3 prostate cancer cells
    Sarah K. Schröder et al, 2020, Cytokine CrossRef
18. Addition of metformin for non-small cell lung cancer patients receiving antineoplastic agents
    Yan Wang et al, 2023, Frontiers in Pharmacology CrossRef
19. Metformin exhibits antineoplastic effects on Pten-deficient endometrial cancer by interfering with TGF-β and p38/ERK MAPK signalling
    Anna Ruiz-Mitjana et al, 2023, Biomedicine & Pharmacotherapy CrossRef
20. Phytochemical Profile, Antioxidant and Antitumor Activities of Green Grape Juice
    Mohamad Nasser et al, 2020, Processes CrossRef
21. Inactivated Sendai virus induces apoptosis and autophagy via the PI3K/Akt/mTOR/p70S6K pathway in human non-small cell lung cancer cells
    Quan Zhang et al, 2015, Biochemical and Biophysical Research Communications CrossRef
22. Metformin induces cell cycle arrest at the G1 phase through E2F8 suppression in lung cancer cells
    Dong Hao Jin et al, 2017, Oncotarget CrossRef
23. Will We Unlock the Benefit of Metformin for Patients with Lung Cancer? Lessons from Current Evidence and New Hypotheses
    Pedro Barrios-Bernal et al, 2022, Pharmaceuticals CrossRef
24. Metformin Synergizes with PD-L1 Monoclonal Antibody Enhancing Tumor Immune Response in Treating Non-Small Cell Lung Cancer and Its Molecular Mechanism Investigation
    Yifan Wang et al, 2022, Evidence-Based Complementary and Alternative Medicine CrossRef
25. A Novel Combination of Sotorasib and Metformin Enhances Cytotoxicity and Apoptosis in KRAS-Mutated Non-Small Cell Lung Cancer Cell Lines through MAPK and P70S6K Inhibition
    Pedro Barrios-Bernal et al, 2023, International Journal of Molecular Sciences CrossRef